Scott Requadt
CEO · Talaris Therapeutics
Scott Requadt has operating and investment experience in the biopharmaceutical industry including therapeutics, medtech and diagnostics.
Entrepreneurship Corporate Development Life Sciences Biotechnology Venture Capital
Klaus Ley, MD
Founding Director · Immunology Center of Georgia
Klaus Ley is exploring the role our immune response plays in atherosclerosis and other autoimmune diseases.
T lymphocytes Immunology Vaccines atherosclerosis Integrins
Robert Garry
Professor · Tulane University
Dr. Garry has published over 100 papers in the area of retrovirology
COVID-19 Pathology Lassa Fever Molecular Mechanisms of Viral Pathogenesis Ebola